DuPont Sees Immune Health Probiotic Sales Opening Window On More Microbial Use In Nutrition

While stockpiling for immune health support drove early sales growth in response to the pandemic, probiotic sales likely will continue increasing, says DuPont Nutrition probiotic marketing head Vanessa Bailey. “My gut tells me I think we could see some sustained increase. There’s going to be some difference in how we behave.”

Bacteria cells

DuPont Nutrition & Biosciences was providing the industry’s largest variety of probiotic strains for food and dietary supplements before the coronavirus pandemic spiked consumer interest in boosting immune health. With more consumers turning to probiotics to strengthen resistance to the virus, it looks for demand to increase from its customers for strains across its microbial portfolio.

“A large portion of the people out there who are taking probiotics were taking them for immune health already,” said...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Strategy

Expanded Distribution In US Helps Drive Up BioGaia Sales

 
• By 

Swedish probiotics player BioGaia is reaping the benefits of increased marketing investments and distribution in the US.

Over The Counter: Seizing The Healthy Aging Opportunity, With Prime Fifty’s Max Gowland

 
• By 

HBW Insight speaks to Prime Fifty founder and managing director Max Gowland about the science behind healthy aging and the opportunity for the consumer health industry.

Nestlé Puts VMS Value Brands On Chopping Block To Focus On Premium Market

 
• By 

Nature’s Bounty, Osteo Bi-Flex and Puritan’s Pride are among the dietary supplement brands under strategic review by Nestle as the firm shifts its focus to the premium end of the market.

Stada Acquires Fortacell To Grow In Balkans

 
• By 

Stada's Serbian subsidiary Hemofarm has enhanced its offering in the dietary supplements category with the acquisition of Fortacell from Goodwill Pharma.

More from Business

Change In P&G’s Helm Coming As Planning For Impact From Tariff Increases In Difficulty

 

Even as CEO Jon Moeller and lead board member Joe Jiminez as well as analysts state confidence the firm’s growth strategy will continue with the executive suite change, the impact of tariff policies could put a dent in its results.

Over The Counter: Seizing The Healthy Aging Opportunity, With Prime Fifty’s Max Gowland

 
• By 

HBW Insight speaks to Prime Fifty founder and managing director Max Gowland about the science behind healthy aging and the opportunity for the consumer health industry.

Reckitt Leans On Europe As It Resets Mucinex In US

 
• By 

Decision to reformulate Mucinex sinus products without phenylephrine hits Reckitt's Q2 sales but the firm says it is preparing for upcoming cold & flu season with new marketing push.